Progression after chemotherapy is a novel predictor of poor outcomes after pulmonary metastasectomy in sarcoma patients.

@article{Stephens2011ProgressionAC,
  title={Progression after chemotherapy is a novel predictor of poor outcomes after pulmonary metastasectomy in sarcoma patients.},
  author={Elizabeth H Stephens and Shanda Haley Blackmon and Arlene M. Correa and J. L. A. Roth and David Rice and Wayne Lewis Hofstetter and Robert Benjamin and Reza John Mehran and Stephen G Swisher and Garrett Lyndon Walsh and Ara Asadur Vaporciyan},
  journal={Journal of the American College of Surgeons},
  year={2011},
  volume={212 5},
  pages={821-6}
}
BACKGROUND Sarcoma patients with pulmonary metastases frequently receive chemotherapy before resection. We hypothesized that measurable progression after chemotherapy is a novel predictor of poor outcomes in sarcoma patients undergoing pulmonary metastasectomy. STUDY DESIGN We conducted a retrospective review of patients between 1998 and 2006 identifying those with sarcoma in whom lung metastases developed as their first site of recurrence, received chemotherapy for their metastases, and then… CONTINUE READING
7 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-7 of 7 extracted citations

Similar Papers

Loading similar papers…